Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
about
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertasesIdentification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytesInteractions between human complement components factor H, factor I and C3bPlasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.Identification of complement regulatory domains in vaccinia virus complement control protein.Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) diseaseTargeting of functional antibody-CD59 fusion proteins to a cell surface.Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).Localization by site-directed mutagenesis of the site in human complement factor H that binds to Streptococcus pyogenes M protein.Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor proteinThe role of complement component C3b and its receptors in sperm-oocyte interaction.Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.Characterization of complement receptor 1 domains for prevention of complement-mediated red cell destruction.Localization of Knops system antigens in the long homologous repeats of complement receptor 1.Identification of residues within the 727-767 segment of human complement component C3 important for its interaction with factor H and with complement receptor 1 (CR1, CD35).A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.Prediction from sequence comparisons of residues of factor H involved in the interaction with complement component C3b.Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis.A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases
P2860
Q22010707-0E7EA90B-DDBA-4332-A820-9096A2E4EB83Q22010812-285AF1B7-264A-48E9-9090-9FB8C53EB077Q24530290-150B9B50-A09F-45AB-A34A-31ED73E46C42Q30425504-5F4661B7-BD0B-4ECA-8250-F0E84736AFA2Q30447940-5561BB62-E9EA-4187-8FFA-8103DCB2757BQ33769083-45868E5A-A592-409A-A3DA-BA3E03B00031Q33834216-60A17B3A-7890-481C-B52A-39E7E58CC38DQ34066011-3FF629B7-3861-4E07-847D-D93717E2B11EQ34584708-20018FB9-F7A8-4C2E-B28A-A2E9B7B4CD32Q35566789-61191C02-7496-4503-AA67-1F6C6DF0A153Q36364346-D51E3F1E-FE50-4769-B79A-20CB0B99269FQ36630669-A4D65C67-2EAB-4506-8A3C-95C313EE9180Q37306486-F44F992E-6478-4252-80FA-17EB0E34751AQ40452822-EC3F99B1-31C9-4516-A79F-6E2139EB938DQ40766198-E343C417-9DBB-4455-87E6-362C644877C8Q40973594-AE05B2B9-784E-44BC-8FCA-56D341467DD9Q41896275-52DE585C-AAA7-478C-AC4A-CEB639DD967BQ41906560-B56F39AC-7527-46D5-BF87-8477B4E64C23Q45870165-E7233F24-E434-4379-B7D8-38B5D827F225Q46938672-7D8D81D1-2064-45D7-A561-832CD9CEB5C2Q58803483-2A3A768A-90C5-4598-A61A-160340BE6B58
P2860
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@ast
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@en
type
label
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@ast
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@en
prefLabel
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@ast
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@en
P2093
P2860
P356
P1476
Mapping of the C3b-binding sit ...... chimeric complement inhibitor.
@en
P2093
A K Matsumoto
D T Fearon
J M Ahearn
L B Klickstein
T J Bartow
P2860
P304
P356
10.1084/JEM.174.6.1451
P407
P577
1991-12-01T00:00:00Z